Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
09/2003
09/24/2003EP1345905A1 Potassium channel inhibitors
09/24/2003EP1345902A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same
09/24/2003EP0984959B1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
09/24/2003CN1444573A Carboxamide compounds and their use as antagonists of human 11CBY receptor
09/24/2003CN1444567A 咪唑衍生物 Imidazole derivatives
09/24/2003CN1444566A Imidazolyl derivatives
09/24/2003CN1444565A Efficient ligand-mediated ullmann coupling of anilines and azoles
09/24/2003CN1122026C Carbonyl diimidazoles, their ester derivatives and method for their prodn
09/24/2003CN1121859C Process for preparing pharmaceutical composition for treatment or prevention hypertension
09/23/2003US6624324 Reacting a cyclic anhydride with an alcohol in presence of an asymmetric catalyst containing Lewis acid and an optically active ligand selected from a diol, aminoalcohol or bisoxazoline compound
09/23/2003US6624309 Administering 4-heterocyclicbenzamide derivative
09/23/2003US6624270 Copolymers derived from vinyl dicyanoimidazoles and other monomers
09/23/2003US6624172 Imidazonaphthyridines
09/23/2003US6623989 Nonvolatile ferroelectric memory and method for fabricating the same
09/23/2003CA2127110C Carbamates and crop protection agents containing them
09/18/2003WO2003076432A1 Benzodiazepine-substituted piperidines for utilization in the treatment of cardiovascular diseases
09/18/2003WO2003076422A1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076417A2 Oxo-azabicyclic compounds
09/18/2003WO2003076416A1 Oxo azabicyclic compounds
09/18/2003WO2003076412A1 Novel hairpin polyamide
09/18/2003WO2003076411A1 Process for producing optically active sulfoxide derivative
09/18/2003WO2003076406A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
09/18/2003WO2003076404A1 Chain oligolactic acid thioester
09/18/2003WO2003076374A1 PROCESS FOR PRODUCING trans-4-AMINO-1-CYCLOHEXANECARBOXYLIC ACID DERIVATIVE
09/18/2003WO2003076366A2 A method for preparing organic fluorocompounds
09/18/2003WO2003075921A2 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
09/18/2003WO2003075857A2 Amino-methyl substituted tetracycline compounds
09/18/2003WO2003075836A2 Cathepsin cysteine protease inhibitors
09/18/2003WO2003053915A3 Compounds for the treatment of inflammatory disorders
09/18/2003WO2003053368A3 Chalcone derivatives and their use to treat diseases
09/18/2003WO2002102742A3 Method for the catalytic oxidative separation of cyclic saturated and unsaturated compounds
09/18/2003WO2002076925A3 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
09/18/2003WO2002062750A9 Cannabinoid receptor ligands
09/18/2003US20030176670 Multivalent macrolide antibiotics
09/18/2003US20030176512 Inhibits abnormal cellular proliferation and restores or prevents inhibition of cellular apoptosis
09/18/2003US20030176482 Imidazole derivatives or their salts
09/18/2003US20030176481 Novel imidazole derivatives with anti-inflammatory activity
09/18/2003US20030176465 Cyclic amino acid derivatives
09/18/2003CA2480001A1 Chain oligolactic acid thioester
09/18/2003CA2479071A1 Process for producing optically active sulfoxide derivative
09/18/2003CA2478706A1 Oxo-azabicyclic compounds
09/18/2003CA2478652A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
09/18/2003CA2476031A1 Novel substituted piperidines, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof
09/17/2003EP1344777A1 Imidazole derivatives, process for their preparation and their use
09/17/2003EP1343805A1 Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration
09/17/2003EP1343775A2 Piperazine derivatives
09/17/2003EP1343561A1 Serine protease inhibitors
09/17/2003CN1443173A Substituted imidazoles as TAFI a inhibitors
09/17/2003CN1443154A 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds
09/17/2003CN1442410A Improved method of preparing secnidazole
09/17/2003CN1121404C Antifungal agent and its preparing process and intermediate
09/16/2003US6620942 Forming a histamine monohydrochloride containing solution from a decarboxylated L- histidine solution by addition of hydrogen chloride and forming histamine dihydrochloride, determining total impurities by HPLC gradient analysis
09/16/2003US6620849 Bicyclic sulfanimde compounds useful for the treatment of cardiac arrhythmias
09/16/2003US6620827 PPARγ modulators
09/16/2003US6620826 N-phenyl imidazole derivatives; cardiovascular disorders, hypotensive agents, kidney failure
09/16/2003US6620820 Inhibitors of bone reabsorption and antagonists of vitronectin receptors
09/16/2003CA2249009C Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors
09/16/2003CA2068089C Method and compositions for using non-ionic contrast agents to reduce the risk of clot formulation in diagnostic procedures
09/12/2003WO2003074550A2 Pin1-modulating compounds and methods of use thereof
09/12/2003WO2003074494A1 Halogen-free ionic liquids
09/12/2003WO2003074487A1 Process for production of optically active compounds
09/12/2003WO2003074475A2 Substituted aryl ketones
09/12/2003WO2003074474A2 Multiple-component solid phases containing at least one active pharmaceutical ingredient
09/12/2003WO2003074008A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003WO2003073986A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003WO2003057221A9 Optical free space signalling system
09/12/2003WO2002022550A3 Chiral amino alcohols and process for preparation of same
09/12/2003CA2478485A1 Method for producing optically active compound
09/12/2003CA2477923A1 Multiple-component solid phases containing at least one active pharmaceutical ingredient
09/12/2003CA2477449A1 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003CA2477423A1 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/11/2003US20030171610 Catalyst asymmetric desymmetrization of prochiral compounds
09/11/2003US20030171598 Aminoacid-iodine complex
09/11/2003US20030171597 Water solvent is substituted with a linear, branched, or cyclic alcohol having 3 or more carbon atoms; the acid is preferentially precipitated from the alcohol; addition of a base enables purification of the alpha amino amide
09/11/2003US20030171593 Process for arylating or vinylating or alkynating a nucleophilic compound
09/11/2003US20030171417 Double salts of fumaric acid with a carnitine and an amino acid and food supplements, dietary supplements and drugs containing same
09/11/2003US20030171351 2'-substituted 1,1'-biphenyl-2-carboxamides, process for their preparation, their use as medicaments, and pharmaceutical preparations comprising them
09/11/2003US20030170381 Piezoelectric element and process for production thereof
09/10/2003EP1342718A1 Method and reagents for n-alkylating ureides
09/10/2003EP1342706A1 Method for producing molecular compound
09/10/2003EP1341779A2 Heterocyclic sulfonamide inhibitors of beta amyloid production
09/10/2003EP1341767A2 Imidazole and benzimidazole caspase inhibitors and uses thereof
09/10/2003EP1341766A1 Imidazolone derivatives for the treatment of viral diseases
09/10/2003EP1341755A1 Carboxylic acid amide derivatives and their use in the treatment of thromboembolic diseases and tumours
09/10/2003EP1341743A2 Organic reactions with co generating materials
09/10/2003EP1194401B1 Diacylhydrazine derivatives
09/10/2003EP0991619B1 Inhibitors of alpha 4-beta 1 mediated cell adhesion
09/10/2003CN1441787A Modulators of TNF-alpha signaling
09/10/2003CN1440971A Vitronectin receptor antagnist, its preparation and use
09/10/2003CN1120663C New composition containing 2-imidazoline-5-one fungicide
09/09/2003US6617346 Inhibit the interaction of MDM2 protein with a p53-like peptide and have antiproliferative activity
09/09/2003US6617344 Heterocyclically substituted benzoylguanidines, process for their preparation, their use as medicaments or diagnostics, and medicaments comprising them
09/09/2003CA2130174C 4-oxo-2 thioxoimidazolidine derivatives as inhibitors of blood platelet aggregation
09/04/2003WO2003072657A1 Process for the preparation of cationic azo compounds
09/04/2003WO2003072541A2 Chemical compounds
09/04/2003WO2003072535A2 Substituted hydroxyethylamines
09/04/2003WO2003072124A1 Induction method for cell differentiation
09/04/2003WO2003047740A3 ENANTIOSELECTIVE TRANSFORMATION OF α,β-UNSATURATED KETONES USING CHIRAL ORGANIC CATALYSTS
09/04/2003WO2003045306A3 Phenoxy amine compounds and compositions for delivering active agents
09/04/2003WO2002032376A3 Bile-acid conjugates for providing sustained systemic concentrations of drugs
1 ... 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 ... 345